Enztec Plans to Increase Rate of Corporate Growth

Enztec recorded 39% revenue growth in 2013, increased staffing and made significant investments in equipment to expand its manufacturing capabilities in 2014. The company has diversified its customer base over the last two years, with around 1/3 of its business coming from sales to sister company OMNI, and the remainder from other orthopaedic equipment suppliers around the world.

“Enztec has always had an international reputation for the quality of our instrument design and manufacturing, and our ability to respond quickly to the requirements of our customers, who are typically multinational companies with large global product programmes,” said Paul Morrison, Founder and General Manager.

“Many of the orthopaedic companies are constrained in their ability to design, engineer and manufacture high-quality surgical instruments,” Mr. Morrison said. “Some of their orthopaedic implant product programmes are stalled by a lack of resources to develop and deliver appropriate instrument sets, which makes a design-to-delivery service like Enztec’s an increasingly attractive option.” (Source: Enztec)

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE